Medical Cannabis Gaining Popularity as a Treatment for Female Orgasmic Disorder
Over 41% of women reportedly have difficulty attaining orgasms and cannabis should be recognized as a treatment in matters of sexual health. This view is gaining ground in the US where medical cannabis is being used to treat Female Orgasmic Disorder in Illinois and Connecticut, with Oregon and New Mexico likely to follow suit .
Medical Cannabis Market Growth Fuelled by Success in Treating Pain, Anxiety, Epilepsy and Cancer-Related Conditions
The pharmacy industry occupies 61% of the international medical cannabis market is investing heavily in the development of new drugs, particularly for chronic pain, epilepsy and cancer-related conditions. That’s according to the World Cannabis Report 2026.
International Medical Cannabis Market Growing at 23% a Year as Regulations Loosen and Patients Seek Alternative Therapies
One of the reasons behind the surging global growth in medical cannabis is the demand by consumers for alternatives to opioids. That, along with better regulatory frameworks and more research on the therapeutic benefits of cannabis, are the main drivers behind the growth of the US$30 billion market
‘Blockbuster’ Cannabis Drug for Chronic Lower Back Pain Set for Release in 2026
The first cannabis-derived product for chronic lower back pain VER-01, is to be launched this year by German pharmaceutical company Vertanical, It claims the new product is twice as effective as existing treatments and opens up a new and uncontroversial pathway for cannabis prescriptions.
Statement from the White House: Increasing Medical Marijuana and Cannabidiol Research.
This is the statement issued by the White House on 18 December 2025, accepting the medical benefits of cannabis and rescheduling its classification as a less dangerous drug. Although this does not allow federal legalization, the executive order is a deeply significant step in US cannabis reform.
Medical Cannabis Marketing Now Positioning Cannabis as a Mainstream Healthcare Product Rather than Alternative Medicine
Leading international cannabis consultancy Prohibition Partners says the European medical cannabis market is maturing at speed, with providers focused on return on investment and a shift in marketing strategies. Cannabis is already well-known as an ‘alternative medicine’, but now marketing departments are looking at repositioning it as part of a cannabis ‘standardized healthcare’ package.
Snowballing Cannabis Research Gives Policy Makers the Evidence to Work With What We Know About the Plant Instead of What We Don’t Know
During 2025 over 4 000 scientific papers on cannabis were published, most with a focus on the therapeutic benefits of the plant. Advocacy group NORML says there is enough of an evidence base for policy-makers to start working with what we know about the plant instead of what we don’t know.
The Health and Wellness Consumer Revolution is Dismantling Cannabis Stigma in South Africa
Cannabis is mainstreaming itself through the growing consumer health and wellness market. More people are turning to nature for solutions to the stress of everyday life and cannabis is one component in a broad consumer movement that is turning to non-pharmaceutical and organic alternatives for mental and physical health.
Germany Medical Cannabis Clampdown Looming: ‘Dealers in White Coats’ Issuing Prescriptions Like a “Pizza Service’
Germany is looking to restrict telephonic prescriptions for medical cannabis as new Federal Drug Commissioner, Hendrik Streeck (pictured here) warns that lax controls are creating ‘dealers in white coats’. He says the system allows doctors to pump out cannabis prescriptions without proper consultations and this cannot continue.
Moroccan Firm Cannaflex Tests South African Medical Cannabis Market with World First Prescription
Moroccan firm Cannaflex has launched a new cannabis-based medicine and the first prescription of the product was to a South African patient last week. This was done through local compliance partners, Gauteng-based DRA Pharmaceuticals, and signals Morocco’s entry into the international medical cannabis market.